Daniel Wagner

488 total citations
16 papers, 334 citations indexed

About

Daniel Wagner is a scholar working on Pharmacology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Daniel Wagner has authored 16 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Daniel Wagner's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Urinary Tract Infections Management (2 papers). Daniel Wagner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Urinary Tract Infections Management (2 papers). Daniel Wagner collaborates with scholars based in United States, Germany and France. Daniel Wagner's co-authors include Peter Langguth, H. Spahn‐Langguth, E. H. Flewellen, W.P. Jones, Abeer Hanafy, John Conklin, Michael B. Bolger, R. Wanitschke, Hildegard Spahn‐Langguth and Wolfgang Tremel and has published in prestigious journals such as Advanced Drug Delivery Reviews, Medicine & Science in Sports & Exercise and Anesthesiology.

In The Last Decade

Daniel Wagner

15 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Wagner United States	8	102	101	99	61	56	16	334
Margareta Hammarlund Sweden	8	82 0.8×	53 0.5×	62 0.6×	57 0.9×	61 1.1×	9	381
Klaus D. Raemsch Germany	6	61 0.6×	74 0.7×	32 0.3×	90 1.5×	49 0.9×	8	376
P. J. Pentik�inen Finland	8	48 0.5×	42 0.4×	64 0.6×	46 0.8×	73 1.3×	9	379
VA John United Kingdom	11	43 0.4×	37 0.4×	72 0.7×	36 0.6×	74 1.3×	25	346
Aziz Laurent United States	12	67 0.7×	58 0.6×	27 0.3×	42 0.7×	40 0.7×	15	416
Mark R. Stiles United States	9	90 0.9×	68 0.7×	25 0.3×	16 0.3×	45 0.8×	13	416
P. Anderson Sweden	13	51 0.5×	45 0.4×	26 0.3×	41 0.7×	68 1.2×	20	413
Margareth Gabrielsson Sweden	7	44 0.4×	68 0.7×	21 0.2×	103 1.7×	86 1.5×	10	348
Patricia M. Plezia United States	13	117 1.1×	121 1.2×	28 0.3×	23 0.4×	23 0.4×	31	620
M. Guerret France	13	56 0.5×	35 0.3×	30 0.3×	60 1.0×	52 0.9×	26	374

Countries citing papers authored by Daniel Wagner

Since Specialization

Citations

This map shows the geographic impact of Daniel Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wagner more than expected).

Fields of papers citing papers by Daniel Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wagner. The network helps show where Daniel Wagner may publish in the future.

Co-authorship network of co-authors of Daniel Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Wagner. A scholar is included among the top collaborators of Daniel Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Wagner. Daniel Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fischer, Jürgen R., Daniel Wagner, Ann Wenzel, et al.. (2024). CBCT-based online adaptive radiotherapy of the prostate bed: first clinical experience and comparison to nonadaptive conventional IGRT. Strahlentherapie und Onkologie. 201(8). 767–778. 5 indexed citations

Hopf, Johannes Christof, et al.. (2022). Atypische Femurfraktur. Die Unfallchirurgie. 126(1). 72–76.

Martin, W. H., et al.. (2014). Arm Exercise Myocardial Perfusion Imaging for Prognostication of Long-Term Outcome. Medicine & Science in Sports & Exercise. 46(12). 2216–2223. 2 indexed citations

Martin, W. H., et al.. (2013). Arm exercise as an alternative to pharmacologic stress testing: Arm exercise stress testing and outcome. American Heart Journal. 167(2). 169–177. 5 indexed citations

Wagner, Daniel, et al.. (2006). Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans. European Journal of Pharmaceutical Sciences. 29(3-4). 231–239. 18 indexed citations

Wagner, Daniel, et al.. (2006). In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect. Pharmaceutical Research. 23(8). 1712–1720. 49 indexed citations

Wagner, Daniel, et al.. (2003). Different Dissolution Media Lead to Different Crystal Structures of Talinolol with Impact on Its Dissolution and Solubility. Drug Development and Industrial Pharmacy. 29(8). 891–902. 13 indexed citations

Wagner, Daniel, et al.. (2001). Intestinal drug efflux: formulation and food effects. Advanced Drug Delivery Reviews. 50. S13–S31. 91 indexed citations

Wagner, Daniel, et al.. (1995). Steady-state human pharmacokinetics and bioavailability of guaifenesin and pseudoephedrine in a sustained-release tablet relative to immediate-release liquids. International Journal of Pharmaceutics. 114(2). 171–176. 4 indexed citations

10.

Lambert, Amaury, et al.. (1991). [Intestinal absorption of insulin with a new telemetric shuttle in dogs].. PubMed. 15(3). 187–93. 4 indexed citations

11.

Wagner, Daniel, et al.. (1989). Absorption of orally, intraduodenally, and intraileally administered nitrofurantoin in man. International Journal of Pharmaceutics. 57(2). 177–180. 3 indexed citations

12.

Flewellen, E. H., T. E. Nelson, W.P. Jones, et al.. (1984). Dantrolene Dose Response in Awake Man. Survey of Anesthesiology. 28(3). 169–169. 2 indexed citations

13.

Flewellen, E. H., et al.. (1983). Dantrolene Dose Response in Awake Man. Anesthesiology. 59(4). 275–280. 110 indexed citations

14.

Conklin, John, et al.. (1973). Further studies on nitrofurantoin excretion in dog hepatic bile. British Journal of Pharmacology. 48(2). 273–277. 7 indexed citations

15.

Conklin, John & Daniel Wagner. (1971). Excretion of nitrofurantoin in dog hepatic bile. British Journal of Pharmacology. 43(1). 140–150. 9 indexed citations

16.

Conklin, John, et al.. (1969). Urinary Drug Excretion in Dogs During Therapeutic Doses of Different Nitrofurantoin Dosage Forms. Journal of Pharmaceutical Sciences. 58(11). 1365–1368. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact